Vaccination against tumor neovascularization: Promise and reality

26Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Immunization against angiogenic-associated antigens selectively expressed on tumor vasculature provides for a novel strategy to block tumor growth.The feasibility of this approach has recently been borne out in several reports demonstrating that the protein or DNA of angiogenic molecules, such as VEGF-R2, can be used as vaccines to generate an effective cytotoxic T cell and antibody response against tumor vessels, thereby blocking tumor growth and metastasis.

Cite

CITATION STYLE

APA

Rafii, S. (2002). Vaccination against tumor neovascularization: Promise and reality. Cancer Cell. Cell Press. https://doi.org/10.1016/S1535-6108(02)00208-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free